Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jhon Carlos Castaño-Osorio has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatitis E Virus Genotype 3 in Quindío, Colombia: One Health Surveillance and First Genomic Characterization Reveal Cryptic Regional Divergence

    by Maria Mercedes González, Omar David Moreno, Leonardo Padilla-Sanabria, Jhon Carlos Castaño-Osorio

    Hepatitis E virus genotype 3 (HEV-3) is a zoonotic pathogen whose burden in Latin America remains underestimated. We conducted a cross-sectional One Health surveillance study (2019–2024) in Quindío, Colombia, testing 42 pig fecal, 8 farm runoff, 4 tributary water samples, and 5 clinical serum samples from patients with hepatitis of undetermined etiology by reverse transcription quantitative PCR (RT-qPCR). Positive and selected clinical/environmental samples underwent Oxford Nanopore MinION sequencing targeting the open reading frame 2 and 3 (ORF2/ORF3) junction, k-mer fingerprinting (k = 25), consensus generation, phylogenetic analysis, and Sanger confirmation. HEV RNA was detected in 8/42 pig fecal samples (19.0%), 4/8 runoff samples (50.0%), 1/4 tributary samples (25.0%), and 4/5 serum samples (80.0%). K-mer analysis identified strong HEV signals in two clinical samples (44.5% and 39.5% of reads) and wastewater (97.2%). Phylogenetic analysis classified Colombian isolates within HEV-3 (bootstrap 83%), while Sanger sequencing confirmed HEV-specific motifs. Two sequences were deposited in GenBank (PZ262436, PZ262437), representing the first Colombian HEV-3 genomic records. These findings demonstrate HEV-3 circulation across porcine, environmental, and human compartments and highlight substantial genomic divergence, supporting locally calibrated molecular approaches and strengthened One Health genomic surveillance in Colombia and Latin America.

  • Inhibitory Effects of Oxysterlina 3, Satanin 1, and Curvicin Cecropins on the Growth and stx2 Gene Expression of Shiga Toxin-Producing Escherichia coli (STEC)

    by Edwin Stiven Quiguanás Guarín, Edwin Stiven Quiguanás, Yuly Andrea Ramírez Tabares, Jhon Carlos Castaño Osorio, Lily Johana Toro, Leonardo Padilla Sanabria, Germán Alberto Téllez Ramírez, Germán Alberto Téllez

  • Dengue and endothelium: a perspective on the pathophysiological implications of endothelial activation in dengue and its therapeutic possibilities

    by Simón Gómez- Barrera, Juan Manuel Moreno- Hortua, Juan Carlos Gallego- Gómez, María Mercedes González de Schroeder, Jhon Carlos Castaño- Osorio

    Introduction: Dengue is a widely spread viral febrile illness, with nearly half of the world’s population, approximately four billion people, living in areas at risk of dengue infection. It is often the leading cause of illness in these high-risk areas. Dengue is caused by four virus serotypes (Dengue 1, Dengue 2, Dengue 3, and Dengue 4). This virus is transmitted through the bites of infected female mosquitoes, primarily Aedes aegypti and Aedes albopictus. There is no specific medication to treat dengue, the and current management of the disease is symptomatic. Thus, an urgent search for specific therapeutic alternatives targeting the virus or the pathophysiological mechanisms responsible for severe forms of the disease is critical. The aim was to gather experimental evidence on the significance of endothelial activation in the pathophysiology of dengue, as available in the scientific literature. Materials and methods: A literatura search were conducted in English using the PubMed, Scopus, and ScienceDirect databases with the keywords dengue, endothelium, pathophysiology, and endothelial activation. Results: Experimental evidence has shown that endothelial dysfunction is central to the clinical manifestations of severe dengue. Discussion: The identification of pathophysiological mechanisms at the endotelial cell level has revealed numerous therapeutic targets for dengue, which need to be validated through clinical studies.


  • Open Access

    Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity

    by Melissa Rodríguez, Lily J. Toro, Carolina Firacative, Beatriz L. Gómez, Bruno Rivas-Santiago, David Andreu, Jhon C. Castaño, German A. Téllez, Julián E. Muñoz

    The number of fungal infections is steadily increasing, with considerable morbidity and mortality. Additionally, antifungal resistance is a growing concern, highlighting the need to develop new treatment options. One alternative is the use of antimicrobial peptides (AMPs). The aim of this study was to assess the in vitro and in vivo antifungal activity of designed short AMPs, Act-6 and Act 8-20, derived from cecropin transcripts of beetles from the family Scarabaeidae, against eight reference strains of the pathogenic yeasts Candida and Cryptococcus. We also evaluated the effect of these modified AMPs on the biofilm, morphogenesis, and cell morphology of Candida albicans, as well as the in vivo activity via a murine model of disseminated candidiasis. The AMPs herein analyzed exhibit differential antifungal activity against the yeasts assessed, and inhibit biofilm, hyphae, and pseudohyphae formation with morphological alterations in C. albicans. Moreover, the fungal load in mice treated with these AMPs significantly decreased. Altogether, our results suggest that Act-6 and Act 8-20 are promising antifungal molecules to control mycoses.


  • Open Access

    La biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo

    by Jhon Carlos Castaño Osorio

    Biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo. Infectio 2024; 24(4): 203-205 las poblaciones y dentro de ellas, de las especies autóctonas, silvestres y domesticadas se constituyan en barreras naturales para microorganismos y sus vectores, permanezcan confinados en sus entornos ecosistémicos naturales y evitar o minimizar, la ocurrencia de una nueva pandemia, tal como lo que vivimos recientemente con la COVID-19.

  • Open Access

    Assessment of Antimicrobial and Cytotoxic Activities of Liposomes Loaded with Curcumin and Lippia origanoides Essential Oil

    by Juan Pablo Bedoya-Agudelo, Jhon Esteban López-Carvajal, Edwin Stiven Quiguanás-Guarín, Nestor Cardona, Leonardo Padilla-Sanabria, Jhon Carlos Castaño-Osorio

    (1) Introduction: Curcumin and Lippia origanoides essential oils have a broad spectrum of biological activities; however, their physicochemical instability, low solubility, and high volatility limit their therapeutic use. Encapsulation in liposomes has been reported as a feasible approach to increase the physicochemical stability of active substances, protect them from interactions with the environment, modulate their release, reduce their volatility, improve their bioactivity, and reduce their toxicity. To date, there are no reports on the co-encapsulation of curcumin and Lippia origanoides essential oils in liposomes. Therefore, the objective of this work is to prepare and physiochemical characterize liposomes loaded with the mixture of these compounds and to evaluate different in vitro biological activities. (2) Methods: Liposomes were produced using the thin-layer method and physiochemical characteristics were calculated. The antimicrobial and cytotoxic activities of both encapsulated and non-encapsulated compounds were evaluated. (3) Results: Empty and loaded nanometric-sized liposomes were obtained that are monodisperse and have a negative zeta potential. They inhibited the growth of Staphylococcus aureus and did not exhibit cytotoxic activity against mammalian cells. (4) Conclusions: Encapsulation in liposomes was demonstrated to be a promising strategy for natural compounds possessing antimicrobial activity.


  • Open Access

    Articulación de la medicina alternativa y complementaria en el Sistema de Seguridad Social en el Quindío - Colombia durante el 2020

    by Olga Alicia Nieto Cárdenas, Jhon Carlos Castaño Osorio

    Objetivo Describir la oferta de los servicios de medicina alternativa y complementaria (mac) en el departamento del Quindío y su articulación en las instituciones del Sistema General de Seguridad Social en Salud (SGSSS). Metodología Estudio descriptivo sobre la oferta de mac en el Registro Especial de Prestadores de Servicios de Salud (reps), las características del ejercicio médico y el acceso, la articulación y la integración en la oferta pública y privada. Resultados Se identificaron veintidós prestadores registrados en el reps que ejercen en la consulta médica privada, número que no ha aumentado desde el año 2010. Se evidenció prestación de mac en seis planes complementarios: dos aseguradoras, dos administradoras de planes de beneficios y dos que ofrecen un carnet de descuentos. Se identificaron tres experiencias de oferta de mac en instituciones públicas del primer nivel de atención, dos de las cuales subsisten, una de ellas con cobertura a personas del régimen subsidiado. Conclusiones Este trabajo evidencia las barreras de acceso a los servicios de mac, las limitaciones en la oferta en las instituciones públicas del SGSSS y la articulación en algunos planes complementarios en la oferta privada. La oferta de mac en condiciones de equidad es a la fecha un reto y una oportunidad para el SGSSS.

  • Open Access

    Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein

    by Leidy Lorena García-Ariza, Natalia González-Rivillas, Cindy Johanna Díaz-Aguirre, Cristian Rocha-Roa, Leonardo Padilla-Sanabria, Jhon Carlos Castaño-Osorio

    Dengue is an acute febrile illness caused by the Dengue virus (DENV), with a high number of cases worldwide. There is no available treatment that directly affects the virus or the viral cycle. The objective of this study was to identify a compound derived from natural products that interacts with the NS5 protein of the dengue virus through virtual screening and evaluate its in vitro antiviral effect on DENV-2. Molecular docking was performed on NS5 using AutoDock Vina software, and compounds with physicochemical and pharmacological properties of interest were selected. The preliminary antiviral effect was evaluated by the expression of the NS1 protein. The effect on viral genome replication and/or translation was determined by NS5 production using DENV-2 Huh-7 replicon through ELISA and viral RNA quantification using RT-qPCR. The in silico strategy proved effective in finding a compound (M78) with an indole-like structure and with an effect on the replication cycle of DENV-2. Treatment at 50 µM reduced the expression of the NS5 protein by 70% and decreased viral RNA by 1.7 times. M78 is involved in the replication and/or translation of the viral genome.


  • Open Access

    Characterization of six Shiga toxin-producing Escherichia coli (STEC) strains carrying Stx2-phages from Colombia

    by Brayan Stiven Arango, Sebastián Peña Buitrago, Jhon Carlos Castaño Osorio, Claudia Viviana Granobles Velandia

    Shiga toxin producing Escherichia coli (STEC) is a bacterial pathogen that causes diarrhea and severe human diseases like HUS; its main virulence factor are the Shiga toxins (Stx1 and Stx2). Some Stx2 subtypes have been identified and associated with the risk of developing severe illness. Stx toxins are encoded in temperate bacteriophages which control their expression through the lytic cycle that is regulated by the late genes and Q anti-terminator protein. The aim of this work was to characterize six STEC strains carrying Stx2-phages to provide preliminary information and understanding about Stx2 strains from Colombia regarding the Stx production, lytic cycle induction and subtyping of Stx2. Two highlighted strains with higher levels of Stx production and lytic cycle’s induction were observed. All the evaluated strains carried either the Stx2a, Stx2c, or Stx2d subtypes. In addition, most of the strains carried the qO111 allele, and only one strain showed differences in the ninG region. Differences in the evaluated characteristics of the strains were observed, which could indicate the variability of these six STEC strains carrying Stx2-phages.


  • Open Access

    PD1 CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion

    by Delia Piedad Recalde-Reyes, Carlos Andrés Rodríguez-Salazar, Jhon Carlos Castaño-Osorio, María Isabel Giraldo